T cell vaccination in humans: the experience in rheumatoid arthritis

J M van Laar, R R de Vries, F C Breedveld

    Research output: Contribution to journalArticleAcademicpeer-review

    Abstract

    To determine the effects of T cell vaccination (TCV) in patients with rheumatoid arthritis (RA), thirteen RA patients were inoculated with attenuated synovial T lymphocytes which contain the putatively pathogenic cells. The procedure was technically feasible and free from toxicity. Variable clinical and immunological responses were found. However, in one patient with recent onset disease and treated with a defined T cell clone, a temporary beneficial response coincided with depressed mitogen reactivity and a decrease of rheumatoid factors. This study may serve as a lead for future research on TCV in humans.

    Original languageEnglish
    Pages (from-to)S59-62
    JournalClinical and Experimental Rheumatology
    Volume11 Suppl 8
    Publication statusPublished - 1 Mar 1993

    Keywords

    • Animals
    • Arthritis, Rheumatoid
    • Autoantigens
    • Disease Models, Animal
    • Evaluation Studies as Topic
    • Humans
    • Lymphocyte Activation
    • Rheumatoid Factor
    • T-Lymphocytes
    • Vaccination
    • Journal Article

    Fingerprint

    Dive into the research topics of 'T cell vaccination in humans: the experience in rheumatoid arthritis'. Together they form a unique fingerprint.

    Cite this